- News Home
27 November 2013 12:59 pm ,
Vol. 342 ,
Science has exposed a thriving academic black market in China involving shady agencies, corrupt scientists, and...
Paper-selling agencies flourish in the aura of reputable businesses. For some scientists, it may be difficult to tell...
The new head of the National Center for Science Education promises to "fight the good fight" against attacks on...
Analyses of the H7N9 strains isolated from four new cases show that the virus is evolving rapidly, heightening anxiety...
In 2009, Jack Szostak shared a Nobel Prize for his part in discovering the role of telomeres, the end bits of...
Featuring the first lunar rover in 40 years, Chang'e-3 is seen as an important milestone on China's quest to send a...
Data collected by satellites and floating probes have chronicled a 2-decade rise in the temperature and thickness of a...
Cholesterol, the artery-clogging molecule that contributes to cardiovascular disease, has another nasty trick up its...
- 27 November 2013 12:59 pm , Vol. 342 , #6162
- About Us
Stem Cell Lawsuit Finally Over
7 January 2013 11:45 am
The Supreme Court today rejected a request to ban U.S.-funded research on human embryonic stem cells (hESCs). The decision brings to an end a long legal battle that has cast a shadow over hESC studies for over 3 years.
Two scientists who study adult stem cells filed their suit, Sherley v. Sebelius, in August 2009. They argued that new National Institutes of Health (NIH) guidelines lifting restrictions on hESC research violated a law banning federal funds for research that destroys embryos. A year later, the plaintiffs won a preliminary injunction that briefly shut down NIH-funded hESC research until an appeals court stayed the injunction. The appeals court and a trial court later ruled in favor of the government.
In October, the plaintiffs appealed to the Supreme Court. But today, the court "denied certiorari," meaning it rejected their petition.
Amy Comstock Rick, president of the Coalition for the Advancement of Medical Research in Washington, D.C., which supports hESC research, called the decision "a victory for scientists, patients, and the entire biomedical research community. Science can now continue to move forward, knowing the threat to promising research and funding has been eliminated."
*Correction 1:15 p.m., 7 January: A change clarifies that the suit argued against new NIH guidelines that lifted restrictions on hESC research.